Global Inactivated Polio Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 91

Published Date: 01 Apr 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Inactivated Polio Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Inactivated Polio Vaccine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Inactivated Polio Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Inactivated Polio Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Government
    Private Sector

Market segment by Application can be divided into
    Pediatrics
    Adults

The key market players for global Inactivated Polio Vaccine market are listed below:
    Sanofi
    GSK
    Bibcol
    Serum Institute
    Tiantan Biological
    Panacea Biotec
    Bio-Med
    Halfkin Bio-Pharmaceuticals

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Inactivated Polio Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inactivated Polio Vaccine, with price, sales, revenue and global market share of Inactivated Polio Vaccine from 2019 to 2021.
Chapter 3, the Inactivated Polio Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inactivated Polio Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Inactivated Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Inactivated Polio Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Inactivated Polio Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Inactivated Polio Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Government
        1.2.3 Private Sector
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Inactivated Polio Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Pediatrics
        1.3.3 Adults
    1.4 Global Inactivated Polio Vaccine Market Size & Forecast
        1.4.1 Global Inactivated Polio Vaccine Sales in Value (2016-2026))
        1.4.2 Global Inactivated Polio Vaccine Sales in Volume (2016-2026)
        1.4.3 Global Inactivated Polio Vaccine Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Inactivated Polio Vaccine Production Capacity Analysis
        1.5.1 Global Inactivated Polio Vaccine Total Production Capacity (2016-2026)
        1.5.2 Global Inactivated Polio Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Inactivated Polio Vaccine Market Drivers
        1.6.2 Inactivated Polio Vaccine Market Restraints
        1.6.3 Inactivated Polio Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Inactivated Polio Vaccine Product and Services
        2.1.4 Sanofi Inactivated Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Inactivated Polio Vaccine Product and Services
        2.2.4 GSK Inactivated Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Bibcol
        2.3.1 Bibcol Details
        2.3.2 Bibcol Major Business
        2.3.3 Bibcol Inactivated Polio Vaccine Product and Services
        2.3.4 Bibcol Inactivated Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Serum Institute
        2.4.1 Serum Institute Details
        2.4.2 Serum Institute Major Business
        2.4.3 Serum Institute Inactivated Polio Vaccine Product and Services
        2.4.4 Serum Institute Inactivated Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Tiantan Biological
        2.5.1 Tiantan Biological Details
        2.5.2 Tiantan Biological Major Business
        2.5.3 Tiantan Biological Inactivated Polio Vaccine Product and Services
        2.5.4 Tiantan Biological Inactivated Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Panacea Biotec
        2.6.1 Panacea Biotec Details
        2.6.2 Panacea Biotec Major Business
        2.6.3 Panacea Biotec Inactivated Polio Vaccine Product and Services
        2.6.4 Panacea Biotec Inactivated Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Bio-Med
        2.7.1 Bio-Med Details
        2.7.2 Bio-Med Major Business
        2.7.3 Bio-Med Inactivated Polio Vaccine Product and Services
        2.7.4 Bio-Med Inactivated Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Halfkin Bio-Pharmaceuticals
        2.8.1 Halfkin Bio-Pharmaceuticals Details
        2.8.2 Halfkin Bio-Pharmaceuticals Major Business
        2.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product and Services
        2.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Inactivated Polio Vaccine Sales by Manufacturer
    3.1 Global Inactivated Polio Vaccine Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Inactivated Polio Vaccine Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Inactivated Polio Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Inactivated Polio Vaccine Manufacturer Market Share
        3.4.2 Top 6 Inactivated Polio Vaccine Manufacturer Market Share
    3.5 Global Inactivated Polio Vaccine Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Inactivated Polio Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Inactivated Polio Vaccine Market Size by Region
        4.1.1 Global Inactivated Polio Vaccine Sales in Volume by Region (2016-2026)
        4.1.2 Global Inactivated Polio Vaccine Revenue by Region (2016-2026)
    4.2 North America Inactivated Polio Vaccine Revenue (2016-2026)
    4.3 Europe Inactivated Polio Vaccine Revenue (2016-2026)
    4.4 Asia-Pacific Inactivated Polio Vaccine Revenue (2016-2026)
    4.5 South America Inactivated Polio Vaccine Revenue (2016-2026)
    4.6 Middle East and Africa Inactivated Polio Vaccine Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Inactivated Polio Vaccine Sales in Volume by Type (2016-2026)
    5.2 Global Inactivated Polio Vaccine Revenue by Type (2016-2026)
    5.3 Global Inactivated Polio Vaccine Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Inactivated Polio Vaccine Sales in Volume by Application (2016-2026)
    6.2 Global Inactivated Polio Vaccine Revenue by Application (2016-2026)
    6.3 Global Inactivated Polio Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Inactivated Polio Vaccine Sales by Type (2016-2026)
    7.2 North America Inactivated Polio Vaccine Sales by Application (2016-2026)
    7.3 North America Inactivated Polio Vaccine Market Size by Country
        7.3.1 North America Inactivated Polio Vaccine Sales in Volume by Country (2016-2026)
        7.3.2 North America Inactivated Polio Vaccine Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Inactivated Polio Vaccine Sales by Type (2016-2026)
    8.2 Europe Inactivated Polio Vaccine Sales by Application (2016-2026)
    8.3 Europe Inactivated Polio Vaccine Market Size by Country
        8.3.1 Europe Inactivated Polio Vaccine Sales in Volume by Country (2016-2026)
        8.3.2 Europe Inactivated Polio Vaccine Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Inactivated Polio Vaccine Sales by Type (2016-2026)
    9.2 Asia-Pacific Inactivated Polio Vaccine Sales by Application (2016-2026)
    9.3 Asia-Pacific Inactivated Polio Vaccine Market Size by Region
        9.3.1 Asia-Pacific Inactivated Polio Vaccine Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Inactivated Polio Vaccine Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Inactivated Polio Vaccine Sales by Type (2016-2026)
    10.2 South America Inactivated Polio Vaccine Sales by Application (2016-2026)
    10.3 South America Inactivated Polio Vaccine Market Size by Country
        10.3.1 South America Inactivated Polio Vaccine Sales in Volume by Country (2016-2026)
        10.3.2 South America Inactivated Polio Vaccine Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Inactivated Polio Vaccine Sales by Type (2016-2026)
    11.2 Middle East & Africa Inactivated Polio Vaccine Sales by Application (2016-2026)
    11.3 Middle East & Africa Inactivated Polio Vaccine Market Size by Country
        11.3.1 Middle East & Africa Inactivated Polio Vaccine Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Inactivated Polio Vaccine Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Inactivated Polio Vaccine Typical Distributors
    12.3 Inactivated Polio Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Inactivated Polio Vaccine Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Inactivated Polio Vaccine Revenue by Application, (USD Million), 2021-2026
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Inactivated Polio Vaccine Product and Services
    Table 6. Sanofi Inactivated Polio Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. GSK Basic Information, Manufacturing Base and Competitors
    Table 8. GSK Major Business
    Table 9. GSK Inactivated Polio Vaccine Product and Services
    Table 10. GSK Inactivated Polio Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Bibcol Basic Information, Manufacturing Base and Competitors
    Table 12. Bibcol Major Business
    Table 13. Bibcol Inactivated Polio Vaccine Product and Services
    Table 14. Bibcol Inactivated Polio Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Serum Institute Basic Information, Manufacturing Base and Competitors
    Table 16. Serum Institute Major Business
    Table 17. Serum Institute Inactivated Polio Vaccine Product and Services
    Table 18. Serum Institute Inactivated Polio Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Tiantan Biological Basic Information, Manufacturing Base and Competitors
    Table 20. Tiantan Biological Major Business
    Table 21. Tiantan Biological Inactivated Polio Vaccine Product and Services
    Table 22. Tiantan Biological Inactivated Polio Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Panacea Biotec Basic Information, Manufacturing Base and Competitors
    Table 24. Panacea Biotec Major Business
    Table 25. Panacea Biotec Inactivated Polio Vaccine Product and Services
    Table 26. Panacea Biotec Inactivated Polio Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Bio-Med Basic Information, Manufacturing Base and Competitors
    Table 28. Bio-Med Major Business
    Table 29. Bio-Med Inactivated Polio Vaccine Product and Services
    Table 30. Bio-Med Inactivated Polio Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 32. Halfkin Bio-Pharmaceuticals Major Business
    Table 33. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product and Services
    Table 34. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Global Inactivated Polio Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
    Table 36. Global Inactivated Polio Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 37. Market Position of Manufacturers in Inactivated Polio Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 38. Global Inactivated Polio Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
    Table 39. Head Office and Inactivated Polio Vaccine Production Site of Key Manufacturer
    Table 40. Inactivated Polio Vaccine New Entrant and Capacity Expansion Plans
    Table 41. Inactivated Polio Vaccine Mergers & Acquisitions in the Past Five Years
    Table 42. Global Inactivated Polio Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 43. Global Inactivated Polio Vaccine Sales by Region (2021-2026) & (K Units)
    Table 44. Global Inactivated Polio Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 45. Global Inactivated Polio Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 46. Global Inactivated Polio Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 47. Global Inactivated Polio Vaccine Sales by Type (2021-2026) & (K Units)
    Table 48. Global Inactivated Polio Vaccine Revenue by Type (2016-2021e) & (USD Million)
    Table 49. Global Inactivated Polio Vaccine Revenue by Type (2021-2026) & (USD Million)
    Table 50. Global Inactivated Polio Vaccine Price by Type (2016-2021e) & (US$/Unit)
    Table 51. Global Inactivated Polio Vaccine Price by Type (2021-2026) & (US$/Unit)
    Table 52. Global Inactivated Polio Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 53. Global Inactivated Polio Vaccine Sales by Application (2021-2026) & (K Units)
    Table 54. Global Inactivated Polio Vaccine Revenue by Application (2016-2021e) & (USD Million)
    Table 55. Global Inactivated Polio Vaccine Revenue by Application (2021-2026) & (USD Million)
    Table 56. Global Inactivated Polio Vaccine Price by Application (2016-2021e) & (US$/Unit)
    Table 57. Global Inactivated Polio Vaccine Price by Application (2021-2026) & (US$/Unit)
    Table 58. North America Inactivated Polio Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 59. North America Inactivated Polio Vaccine Sales by Country (2021-2026) & (K Units)
    Table 60. North America Inactivated Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 61. North America Inactivated Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 62. North America Inactivated Polio Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 63. North America Inactivated Polio Vaccine Sales by Type (2021-2026) & (K Units)
    Table 64. North America Inactivated Polio Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 65. North America Inactivated Polio Vaccine Sales by Application (2021-2026) & (K Units)
    Table 66. Europe Inactivated Polio Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 67. Europe Inactivated Polio Vaccine Sales by Country (2021-2026) & (K Units)
    Table 68. Europe Inactivated Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 69. Europe Inactivated Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 70. Europe Inactivated Polio Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 71. Europe Inactivated Polio Vaccine Sales by Type (2021-2026) & (K Units)
    Table 72. Europe Inactivated Polio Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 73. Europe Inactivated Polio Vaccine Sales by Application (2021-2026) & (K Units)
    Table 74. Asia-Pacific Inactivated Polio Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 75. Asia-Pacific Inactivated Polio Vaccine Sales by Region (2021-2026) & (K Units)
    Table 76. Asia-Pacific Inactivated Polio Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 77. Asia-Pacific Inactivated Polio Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 78. Asia-Pacific Inactivated Polio Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 79. Asia-Pacific Inactivated Polio Vaccine Sales by Type (2021-2026) & (K Units)
    Table 80. Asia-Pacific Inactivated Polio Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 81. Asia-Pacific Inactivated Polio Vaccine Sales by Application (2021-2026) & (K Units)
    Table 82. South America Inactivated Polio Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 83. South America Inactivated Polio Vaccine Sales by Country (2021-2026) & (K Units)
    Table 84. South America Inactivated Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 85. South America Inactivated Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 86. South America Inactivated Polio Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 87. South America Inactivated Polio Vaccine Sales by Type (2021-2026) & (K Units)
    Table 88. South America Inactivated Polio Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 89. South America Inactivated Polio Vaccine Sales by Application (2021-2026) & (K Units)
    Table 90. Middle East & Africa Inactivated Polio Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 91. Middle East & Africa Inactivated Polio Vaccine Sales by Country (2021-2026) & (K Units)
    Table 92. Middle East & Africa Inactivated Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 93. Middle East & Africa Inactivated Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 94. Middle East & Africa Inactivated Polio Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 95. Middle East & Africa Inactivated Polio Vaccine Sales by Type (2021-2026) & (K Units)
    Table 96. Middle East & Africa Inactivated Polio Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 97. Middle East & Africa Inactivated Polio Vaccine Sales by Application (2021-2026) & (K Units)
    Table 98. Direct Channel Pros & Cons
    Table 99. Indirect Channel Pros & Cons
    Table 100. Inactivated Polio Vaccine Typical Distributors
    Table 101. Inactivated Polio Vaccine Typical Customers
List of Figures
    Figure 1. Inactivated Polio Vaccine Picture
    Figure 2. Global Inactivated Polio Vaccine Sales Market Share by Type in 2020
    Figure 3. Government
    Figure 4. Private Sector
    Figure 5. Global Inactivated Polio Vaccine Sales Market Share by Application in 2020
    Figure 6. Pediatrics
    Figure 7. Adults
    Figure 8. Global Inactivated Polio Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 9. Global Inactivated Polio Vaccine Market Size and Forecast (2016-2026) & (USD Million)
    Figure 10. Global Inactivated Polio Vaccine Sales (2016-2026) & (K Units)
    Figure 11. Global Inactivated Polio Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 12. Global Inactivated Polio Vaccine Production Capacity (2016-2026) & (K Units)
    Figure 13. Global Inactivated Polio Vaccine Production Capacity by Geographic Region: 2020 VS 2021
    Figure 14. Inactivated Polio Vaccine Market Drivers
    Figure 15. Inactivated Polio Vaccine Market Restraints
    Figure 16. Inactivated Polio Vaccine Market Trends
    Figure 17. Global Inactivated Polio Vaccine Sales Market Share by Manufacturer in 2020
    Figure 18. Global Inactivated Polio Vaccine Revenue Market Share by Manufacturer in 2020
    Figure 19. Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 20. Top 3 Inactivated Polio Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 21. Top 6 Inactivated Polio Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 22. Global Inactivated Polio Vaccine Sales Market Share by Region (2016-2026)
    Figure 23. Global Inactivated Polio Vaccine Revenue Market Share by Region (2016-2026)
    Figure 24. North America Inactivated Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 25. Europe Inactivated Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 26. Asia-Pacific Inactivated Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 27. South America Inactivated Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 28. Middle East & Africa Inactivated Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 29. Global Inactivated Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 30. Global Inactivated Polio Vaccine Revenue Market Share by Type (2016-2026)
    Figure 31. Global Inactivated Polio Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 32. Global Inactivated Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 33. Global Inactivated Polio Vaccine Revenue Market Share by Application (2016-2026)
    Figure 34. Global Inactivated Polio Vaccine Price by Application (2016-2026) & (US$/Unit)
    Figure 35. North America Inactivated Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 36. North America Inactivated Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 37. North America Inactivated Polio Vaccine Sales Market Share by Country (2016-2026)
    Figure 38. North America Inactivated Polio Vaccine Revenue Market Share by Country (2016-2026)
    Figure 39. United States Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 40. Canada Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Mexico Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Europe Inactivated Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 43. Europe Inactivated Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 44. Europe Inactivated Polio Vaccine Sales Market Share by Country (2016-2026)
    Figure 45. Europe Inactivated Polio Vaccine Revenue Market Share by Country (2016-2026)
    Figure 46. Germany Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. France Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. United Kingdom Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Russia Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Italy Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Asia-Pacific Inactivated Polio Vaccine Sales Market Share by Region (2016-2026)
    Figure 52. Asia-Pacific Inactivated Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 53. Asia-Pacific Inactivated Polio Vaccine Sales Market Share by Region (2016-2026)
    Figure 54. Asia-Pacific Inactivated Polio Vaccine Revenue Market Share by Region (2016-2026)
    Figure 55. China Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Japan Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Korea Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. India Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Southeast Asia Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Australia Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. South America Inactivated Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 62. South America Inactivated Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 63. South America Inactivated Polio Vaccine Sales Market Share by Country (2016-2026)
    Figure 64. South America Inactivated Polio Vaccine Revenue Market Share by Country (2016-2026)
    Figure 65. Brazil Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Argentina Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Middle East & Africa Inactivated Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 68. Middle East & Africa Inactivated Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 69. Middle East & Africa Inactivated Polio Vaccine Sales Market Share by Country (2016-2026)
    Figure 70. Middle East & Africa Inactivated Polio Vaccine Revenue Market Share by Country (2016-2026)
    Figure 71. Turkey Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Egypt Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Saudi Arabia Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. South Africa Inactivated Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Sales Channel: Direct Channel vs Indirect Channel
    Figure 76. Methodology
    Figure 77. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals

Related Reports

Global Inactivated Polio Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Inactivated Polio Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 14 Jan 2022

date Pharma & Healthcare

The Inactivated Polio Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Inactivated Polio Vaccine Supply, Demand and Key Producers, 2023-2029

Global Inactivated Polio Vaccine Supply, Demand and Key Producers, 2023-2029

date 23 Jan 2023

date Pharma & Healthcare

The global Inactivated Polio Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Inactivated Polio Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Inactivated Polio Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).

Global Inactivated Polio Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Inactivated Polio Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Inactivated Polio Vaccine market size was valued at USD 708.4 million in 2023 and is forecast to a readjusted size of USD 945.6 million by 2030 with a CAGR of 4.2% during review period.

Global Inactivated Polio Vaccine Supply, Demand and Key Producers, 2024-2030

Global Inactivated Polio Vaccine Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global Inactivated Polio Vaccine market size is expected to reach $ 945.6 million by 2030, rising at a market growth of 4.2% CAGR during the forecast period (2024-2030).

Product Tags

inactivated polio vaccine

sabin inactivated polio vaccine sipv

Sabin Inactivated Polio vaccine (sIPV)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>